Neutrophil chemotaxis and enzyme release competitive inhibition by a diazoacetamide pepsin inhibitor.
Treatment of human neutrophils with a reagent (diazoacetylnorleucine methyl ester plus copper ion) which covalently labels the active site of the acid proteases, pepsin and cathepsin D, inhibits neutrophil chemotaxis and enzyme release stimulated by the chemoattractants pepstatin and formylmethiony peptides. In contrast, chemotaxis and enzyme release in response to zymosan activated serum are not affected. Furthermore, diazoacetylnorleucine methy ester plus copper competes with [3H]formylmethionyl leucylphenylalanine for binding to neutrophils. Since pepstatin shares binding sites with formylmethionyl leucylphenylalanine, the present data suggest that diazoacetylnorleucine methyl ester plus copper reacts with the neutrophil receptor for pepstatin and formylmethionyl peptides, and thus may be useful in further characterization of this structure.
D000135:Acid Phosphatase / Q000097:blood*; D000328:Adult; D001665:Binding Sites; D002630:Chemotactic Factors / Q000097:blood / Q000494:pharmacology; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D003300:Copper; D006801:Humans; D066298:In Vitro Techniques; D009239:N-Formylmethionine / Q000031:analogs & derivatives; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D009646:Norleucine / Q000031:analogs & derivatives; D009842:Oligopeptides; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D010436:Pepstatins / Q000494:pharmacology
D002630:Chemotactic Factors; D009842:Oligopeptides; D010436:Pepstatins; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine; C000909:N-diazoacetylnorleucine methyl ester; D003300:Copper; D009646:Norleucine; D000135:Acid Phosphatase; D010434:Pepsin A